These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2340944)

  • 1. Clinical and haemodynamic effects of ketanserin in lean and obese hypertensive patients.
    Licata G; Scaglione R; Parrinello G; Capuana G; Mazzola G; Lipari R; Castello R; Galantino L
    J Int Med Res; 1990; 18(2):112-9. PubMed ID: 2340944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and hemodynamic effects of medium-term ketanserin treatment in 2 compared groups of obese and non-obese hypertensive patients].
    Licata G; Scaglione R; Parrinello G; Capuana G; Mazzola G; Lipari R; Galantino L; Castello R
    G Clin Med; 1989 Oct; 70(10):597-603. PubMed ID: 2599284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and hemodynamic effects of medium-term treatment with ketanserin of 2 comparative groups of obese and non-obese hypertensive patients].
    Parrinello G
    Ann Ital Med Int; 1990; 5(4 Pt 2):477-83. PubMed ID: 2102135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of obesity on left ventricular function studied by radionuclide angiocardiography.
    Licata G; Scaglione R; Barbagallo M; Parrinello G; Capuana G; Lipari R; Merlino G; Ganguzza A
    Int J Obes; 1991 Apr; 15(4):295-302. PubMed ID: 2071319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function.
    Scaglione R; Ganguzza A; Corrao S; Parrinello G; Merlino G; Dichiara MA; Arnone S; D'Aubert MD; Licata G
    Int J Obes Relat Metab Disord; 1995 Jun; 19(6):403-9. PubMed ID: 7550525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects on central haemodynamics and body fluid volumes of ketanserin in essential hypertension studies at rest and during dynamic exercise.
    Omvik P; Lund-Johansen P
    J Hypertens; 1983 Dec; 1(4):405-12. PubMed ID: 6681181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension in obese subjects: distinct hypertensive subgroup.
    Licata G; Scaglione R; Capuana G; Parrinello G; Di Vincenzo D; Mazzola G
    J Hum Hypertens; 1990 Feb; 4(1):37-41. PubMed ID: 2345385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal haemodynamic studies in obesity hypertension.
    Reisin E; Messerli FG; Ventura HO; Frohlich ED
    J Hypertens; 1987 Aug; 5(4):397-400. PubMed ID: 3668243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and large arteries' compliance in humans: a cross-over double-blind study.
    De Luca N; Rosiello G; Crispino M; Volpe M; Galletti P; Buzzetti G; Trimarco B
    J Clin Pharmacol; 1988 Apr; 28(4):332-8. PubMed ID: 3292598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and compliance of great arteries in man: a double-blind crossover study].
    Crispino M
    Ann Ital Med Int; 1990; 5(4 Pt 2):469-76. PubMed ID: 2102134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exaggerated haemodynamic and neural responses to involuntary contractions induced by whole-body vibration in normotensive obese versus lean women.
    Dipla K; Kousoula D; Zafeiridis A; Karatrantou K; Nikolaidis MG; Kyparos A; Gerodimos V; Vrabas IS
    Exp Physiol; 2016 Jun; 101(6):717-30. PubMed ID: 27061448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of ketanserin in the treatment of hypertension during coronary artery bypass surgery.
    Richter JA; Barankay A; Göb E; Späth P
    J Cardiovasc Pharmacol; 1986; 8(1):109-15. PubMed ID: 2419672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic response to the S2-serotonergic receptor antagonist, ketanserin, in patients with primary pulmonary hypertension.
    McGoon MD; Vlietstra RE
    Int J Cardiol; 1987 Mar; 14(3):303-9. PubMed ID: 3557709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives.
    Vyssoulis GP; Karpanou EA; Pitsavos CE; Paleologos AA; Kourtis TK; Toutouzas PK
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():81-4. PubMed ID: 2149517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy.
    Bolte AC; van Eyck J; Strack van Schijndel RJ; van Geijn HP; Dekker GA
    Br J Obstet Gynaecol; 1998 Jul; 105(7):723-31. PubMed ID: 9692412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic and metabolic effects of ketanserin in dyslipidaemic hypertensive subjects.
    Letizia C; Sellini M; Scavo D
    Int J Tissue React; 1991; 13(2):91-3. PubMed ID: 1955297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of ketanserin, a new antiserotonergic agent in the treatment of arterial hypertension.
    Ferrara LA; Fasano ML; Soro S; Rubba P; Iannuzzi A
    J Clin Pharmacol; 1985 Apr; 25(3):187-92. PubMed ID: 3158674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of overweight/obesity on cardiovascular responses to acute psychological stress in men aged 50-70 years.
    Torres SJ; Turner AI; Jayasinghe SU; Reynolds J; Nowson CA
    Obes Facts; 2014; 7(6):339-50. PubMed ID: 25428119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differences.
    Chrysant SG; Dunn FG; De Carvalho JG; Adamopoulos PN; Frolich ED
    Arch Intern Med; 1977 Dec; 137(12):1702-5. PubMed ID: 412475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive therapy with ketanserin: effects on central and renal hemodynamics, and microalbuminuria.
    Casagrande P; Valvo E; Bedogna V; Loschiavo C; Giorgetti P; Graziani MS; Maschio G
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):79-83. PubMed ID: 2307549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.